Actively Recruiting

Age: 8Years - 35Years
All Genders
NCT02734277

Type 1 Diabetes Extension Study

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-03-10

111

Participants Needed

12

Research Sites

623 weeks

Total Duration

On this page

Sponsors

N

National Institute of Allergy and Infectious Diseases (NIAID)

Lead Sponsor

I

Immune Tolerance Network (ITN)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long they continue to produce insulin, and * will also assess how changes in the immune system over time relate to the ability to produce insulin. This information could help design better therapies for type 1 diabetes in the future.

CONDITIONS

Official Title

Type 1 Diabetes Extension Study

Who Can Participate

Age: 8Years - 35Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Prior participant in an Immune Tolerance Network (ITN) executive committee approved T1DM study
  • Ability to sign informed consent or assent, as applicable for children
Not Eligible

You will not qualify if you...

  • Any medical condition that the principal investigator believes would interfere with safe completion of the study
  • Inability to comply with the visit schedule and required assessments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 12 locations

1

UCSF School of Medicine

San Francisco, California, United States, 94143

Actively Recruiting

2

Stanford University

Stanford, California, United States, 94305

Actively Recruiting

3

University of Colorado School of Medicine: Barbara Davis Center for Diabetes

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Yale University

New Haven, Connecticut, United States, 06519

Completed

5

Emory University

Atlanta, Georgia, United States, 30322

Withdrawn

6

Indiana University Riley Hospital for Children

Indianapolis, Indiana, United States, 46202

Actively Recruiting

7

University of Iowa Health Care Division of Pediatric Endocrinology

Iowa City, Iowa, United States, 52242

Actively Recruiting

8

Joslin Diabetes Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

9

University of Minnesota

Minneapolis, Minnesota, United States, 55454

Actively Recruiting

10

Children's Mercy Hospital

Kansas City, Missouri, United States, 64108

Actively Recruiting

11

Sanford Research

Sioux Falls, South Dakota, United States, 57104

Completed

12

Benaroya Research Institute

Seattle, Washington, United States, 98101

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here